Idarubicin
Idarubicin
Idarubicin (pronounced: eye-dah-roo-bih-sin) is a type of chemotherapy drug used in the treatment of certain types of cancer, including leukemia and breast cancer. It belongs to the class of drugs known as anthracyclines, which work by interfering with the growth of cancer cells.
Etymology
The name "Idarubicin" is derived from the town of Idar-Oberstein in Germany, where the drug was first synthesized. The suffix "-rubicin" is common to anthracycline drugs, which are named after the ruby-red color of the original compound.
Usage
Idarubicin is used in the treatment of acute myeloid leukemia (AML) and is sometimes used in the treatment of acute lymphoblastic leukemia (ALL). It may also be used in the treatment of metastatic breast cancer. The drug is administered intravenously.
Side Effects
Like all chemotherapy drugs, Idarubicin can cause side effects. These may include nausea, vomiting, hair loss, and mouth sores. More serious side effects can include heart damage, low blood counts, and an increased risk of infection.
Related Terms
- Chemotherapy
- Anthracyclines
- Leukemia
- Breast cancer
- Acute myeloid leukemia (AML)
- Acute lymphoblastic leukemia (ALL)
- Nausea
- Vomiting
- Hair loss
- Mouth sores
- Heart damage
- Low blood counts
- Infection
External links
- Medical encyclopedia article on Idarubicin
- Wikipedia's article - Idarubicin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski